Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy

Serena Bonin, Nunzia Zanotta, Arianna Sartori, Alessio Bratina, Paolo Manganotti, Paolo Manganotti, Giusto Trevisan, Giusto Trevisan, Manola Comar, Manola Comar

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

© 2017 Taylor & Francis. Background: Cerebrospinal fluid (CSF) analysis in patients with particular neurologic disorders is a powerful tool to evaluate specific central nervous system inflammatory markers for diagnostic needs, because CSF represents the specific immune micro-environment to the central nervous system. Methods: CSF samples from 49 patients with multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP), and non-inflammatory neurologic disorders (NIND) as controls were submitted to protein expression profiles of 47 inflammatory biomarkers by multiplex Luminex bead assay to investigate possible differences in the inflammatory process for MS and CIDP. Results: Our results showed differences in CSF cytokine levels in MS and CIDP; in particular, IL12 (p40) was significantly highly expressed in MS in comparison with CIDP and NIND, while SDF-1α and SCGF-β were significantly highly expressed in CIDP cohort when compared to MS and NIND. IL-9, IL-13, and IL-17 had higher expression levels in NIND if compared with the other groups. Conclusions: Our study showed that, despite some common pathogenic mechanisms, central and peripheral nervous system demyelinating diseases, such as MS and CIDP, differ in some specific inflammatory soluble proteins in CSF, underlining differences in the immune response involved in those autoimmune diseases.
Original languageEnglish
Pages (from-to)135-145
Number of pages11
JournalImmunological Investigations
Volume47
Issue number2
DOIs
Publication statusPublished - Feb 17 2018

Fingerprint

Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Multiple Sclerosis
Cerebrospinal Fluid
Nervous System Diseases
Cytokines
Central Nervous System
Interleukin-9
Cerebrospinal Fluid Proteins
Interleukin-13
Interleukin-17
Demyelinating Diseases
Peripheral Nervous System Diseases
Interleukin-12
Autoimmune Diseases
Biomarkers

Keywords

  • central and peripheral nervous system
  • cerebrospinal fluid
  • chronic inflammatory demyelinating polyneuropathy
  • inflammatory biomarkers
  • Multiple sclerosis

Cite this

Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. / Bonin, Serena; Zanotta, Nunzia; Sartori, Arianna; Bratina, Alessio; Manganotti, Paolo; Manganotti, Paolo; Trevisan, Giusto; Trevisan, Giusto; Comar, Manola; Comar, Manola.

In: Immunological Investigations, Vol. 47, No. 2, 17.02.2018, p. 135-145.

Research output: Contribution to journalArticle

Bonin, Serena ; Zanotta, Nunzia ; Sartori, Arianna ; Bratina, Alessio ; Manganotti, Paolo ; Manganotti, Paolo ; Trevisan, Giusto ; Trevisan, Giusto ; Comar, Manola ; Comar, Manola. / Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy. In: Immunological Investigations. 2018 ; Vol. 47, No. 2. pp. 135-145.
@article{a9d95d512cb447fbad280aa491a2bce9,
title = "Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy",
abstract = "{\circledC} 2017 Taylor & Francis. Background: Cerebrospinal fluid (CSF) analysis in patients with particular neurologic disorders is a powerful tool to evaluate specific central nervous system inflammatory markers for diagnostic needs, because CSF represents the specific immune micro-environment to the central nervous system. Methods: CSF samples from 49 patients with multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP), and non-inflammatory neurologic disorders (NIND) as controls were submitted to protein expression profiles of 47 inflammatory biomarkers by multiplex Luminex bead assay to investigate possible differences in the inflammatory process for MS and CIDP. Results: Our results showed differences in CSF cytokine levels in MS and CIDP; in particular, IL12 (p40) was significantly highly expressed in MS in comparison with CIDP and NIND, while SDF-1α and SCGF-β were significantly highly expressed in CIDP cohort when compared to MS and NIND. IL-9, IL-13, and IL-17 had higher expression levels in NIND if compared with the other groups. Conclusions: Our study showed that, despite some common pathogenic mechanisms, central and peripheral nervous system demyelinating diseases, such as MS and CIDP, differ in some specific inflammatory soluble proteins in CSF, underlining differences in the immune response involved in those autoimmune diseases.",
keywords = "central and peripheral nervous system, cerebrospinal fluid, chronic inflammatory demyelinating polyneuropathy, inflammatory biomarkers, Multiple sclerosis",
author = "Serena Bonin and Nunzia Zanotta and Arianna Sartori and Alessio Bratina and Paolo Manganotti and Paolo Manganotti and Giusto Trevisan and Giusto Trevisan and Manola Comar and Manola Comar",
year = "2018",
month = "2",
day = "17",
doi = "10.1080/08820139.2017.1405978",
language = "English",
volume = "47",
pages = "135--145",
journal = "Immunological Investigations",
issn = "0882-0139",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy

AU - Bonin, Serena

AU - Zanotta, Nunzia

AU - Sartori, Arianna

AU - Bratina, Alessio

AU - Manganotti, Paolo

AU - Manganotti, Paolo

AU - Trevisan, Giusto

AU - Trevisan, Giusto

AU - Comar, Manola

AU - Comar, Manola

PY - 2018/2/17

Y1 - 2018/2/17

N2 - © 2017 Taylor & Francis. Background: Cerebrospinal fluid (CSF) analysis in patients with particular neurologic disorders is a powerful tool to evaluate specific central nervous system inflammatory markers for diagnostic needs, because CSF represents the specific immune micro-environment to the central nervous system. Methods: CSF samples from 49 patients with multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP), and non-inflammatory neurologic disorders (NIND) as controls were submitted to protein expression profiles of 47 inflammatory biomarkers by multiplex Luminex bead assay to investigate possible differences in the inflammatory process for MS and CIDP. Results: Our results showed differences in CSF cytokine levels in MS and CIDP; in particular, IL12 (p40) was significantly highly expressed in MS in comparison with CIDP and NIND, while SDF-1α and SCGF-β were significantly highly expressed in CIDP cohort when compared to MS and NIND. IL-9, IL-13, and IL-17 had higher expression levels in NIND if compared with the other groups. Conclusions: Our study showed that, despite some common pathogenic mechanisms, central and peripheral nervous system demyelinating diseases, such as MS and CIDP, differ in some specific inflammatory soluble proteins in CSF, underlining differences in the immune response involved in those autoimmune diseases.

AB - © 2017 Taylor & Francis. Background: Cerebrospinal fluid (CSF) analysis in patients with particular neurologic disorders is a powerful tool to evaluate specific central nervous system inflammatory markers for diagnostic needs, because CSF represents the specific immune micro-environment to the central nervous system. Methods: CSF samples from 49 patients with multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP), and non-inflammatory neurologic disorders (NIND) as controls were submitted to protein expression profiles of 47 inflammatory biomarkers by multiplex Luminex bead assay to investigate possible differences in the inflammatory process for MS and CIDP. Results: Our results showed differences in CSF cytokine levels in MS and CIDP; in particular, IL12 (p40) was significantly highly expressed in MS in comparison with CIDP and NIND, while SDF-1α and SCGF-β were significantly highly expressed in CIDP cohort when compared to MS and NIND. IL-9, IL-13, and IL-17 had higher expression levels in NIND if compared with the other groups. Conclusions: Our study showed that, despite some common pathogenic mechanisms, central and peripheral nervous system demyelinating diseases, such as MS and CIDP, differ in some specific inflammatory soluble proteins in CSF, underlining differences in the immune response involved in those autoimmune diseases.

KW - central and peripheral nervous system

KW - cerebrospinal fluid

KW - chronic inflammatory demyelinating polyneuropathy

KW - inflammatory biomarkers

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85035140327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85035140327&partnerID=8YFLogxK

U2 - 10.1080/08820139.2017.1405978

DO - 10.1080/08820139.2017.1405978

M3 - Article

AN - SCOPUS:85035140327

VL - 47

SP - 135

EP - 145

JO - Immunological Investigations

JF - Immunological Investigations

SN - 0882-0139

IS - 2

ER -